Busca
Exibindo 1591 - 1620 de 2726
The director of Fiocruz Minas, Zélia Profeta, was invited to be a member of the Council on the Economics of Health for All, recently created by the World Health Organization (WHO). The invitation was sent by WHO’s Director-General Tedros Adhanom and Professor Mariana Mazzucato of University College London, who will coordinate the Council.
The creation of the Council on the Economy of Health for All was announced in November 2020, during the 73rd World Health Assembly. The proposal is to put the concept of “health for all” at the center of discussions when thinking about creation of value and…
Article
A study by Fiocruz and WWF-Brasil shows that the wildfires in the Amazon were responsible for the increase in the percentages of hospitalizations due to respiratory problems in the last 10 years (2010-2020) in states with higher numbers of hot spots: Pará, Mato Grosso, Rondônia, Amazonas and Acre. These hospitalizations cost the public treasury almost 1 billion. The survey also points out that the association of the pandemic situation with forest wildfires in the Amazon may have aggravated the health situation of the legal Amazon population, because the pollutants from the wildfires can cause…
Article
Two drugs used against hepatitis C have been proven effective in inhibiting Sars-CoV-2 replication in cells in laboratory studies. The trial is now entering its phase 2: tests in patients. The results of the first phase of the trial, led by researchers of the Oswaldo Cruz Foundation (Fiocruz), were published on April 21 in a paper for the Journal of Antimicrobial Chemotherapy, by Oxford Academic. The results of phase 2 will likely be known in the second semester of 2021.
Images show the action of sofosbuvir and daclastavir in a cell infected with Sars-CoV-2
The trial, which began last week,…
Article
The Presidency of the Oswaldo Cruz Foundation (Fiocruz) signed, on April 20, an international cooperation agreement with the Institute of Global Health of Barcelona (ISGlobal), to establish the basis to implement a joint work plan for the upcoming years. The two institutions have worked together at previous occasions in different research projects and scientific publications. However, the new Memorandum of Understanding formalizes the association and strengthens the intention of the institutions to promote public health and collaboration in important fields, such as neglected tropical…
Article
Published on April 24, the Bulletin of the Fiocruz COVID-19 Observatory, referring to Epidemiological Weeks (EW) 14 and 15, between 4 and 17 April, presents a general overview of the Covid-19 situation in the country and its implications. The new edition shows that the pandemic is hitting younger people. The number of cases and deaths by Covid-19 per age group shows that the differential increase per age group is steady. According to the analysis, the younger age group, from 20 to 29 years old, was the one with the higher number of deaths: 1,081.82%. The age group from 40 to 49 years old (1,…
Article
A study by researchers of the Oxford University shows that the risk of cerebral venous thrombosis (CVT) in people with COVID-19 is considerably higher than in those who have been vaccinated with mRNA (messenger RNA) vaccines, such as those by Pfizer and Moderna. In addition to mRNA vaccines, the analysis also included the Oxford/AstraZeneca immunizer, produced in Brazil by the Oswaldo Cruz Foundation (Fiocruz).
The survey Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine brought…
Article
The emergence of COVID-19 and the entire context of the pandemic humankind has been facing has raised an alert for the possible appearance of other emerging and re-emerging epidemics that may occur as a consequence of the interferences suffered by Brazilian biomes — deforestation and destruction of ecosystems. In a paper published recently in Genetics and Molecular Biology, researchers highlight that the Amazon’s environmental vulnerability when faced with degrading actions the biome has been suffering is a risk to the health of populations, especially when it carries the possibility of the…
Article
Remembered for the second consecutive year, World Chagas Disease Day was marked in Fiocruz on 14/4, with an event that had not only tributes to those who helped in the research and fight against the disease, but also with the look on the future. In addition to the tributes to the researchers of the institution Zilton Andrade and José Rodrigues Coura, who have died, there was the agreement with Unitaid of CUIDA Chagas virtual signing, a project that aims to eliminate the disease congenital transmission in Latin American countries. The initiative, which includes co-financing from the Brazilian…
Article
A “pandemic of inequalities”, which denies people access to water to wash their hands, is one of the factors that have worsened the dissemination of Sars-CoV-2 in Latin America and in the Caribbean. This is the assessment of the UN High Commissioner for Human Rights and former president of Chile, Michelle Bachelet. A physician herself, last Thursday (April 15) she opened the Advanced Seminaries on Global Health and Health Diplomacy of the Center of International Relations in Health (Cris/Fiocruz).
“Those who were already more vulnerable before, such as women, were those most affected by the…
Article
The Conference On Expanding Africa’s Vaccine, organized by the African Union and the Centers for Disease Control in Africa (CDC Africa), held on 12 and 13/4, had the Oswaldo Cruz Foundation (Fiocruz) president as one of the speakers on Tuesday. During Session 8, on the Partnership with Foundations for Vaccine Production, Nísia reaffirmed Fiocruz's commitment to a South-South agenda to support the needs of the African continent in strengthening its health system, preparing for disease emergencies, and providing the population with access to medical care.
The session, moderated by Winnie…
Article
Many viruses can hamper coagulation, including those that cause dengue fever and yellow fever. In more severe cases, they may lead to bleeding. This is why these diseases are considered hemorrhagic viral fevers. In a paper recently published in the science magazine “Memórias do Instituto Oswaldo Cruz”, a group of ten researchers argues that the new coronavirus (SARS-CoV-2) should be the first agent recognized as acting in the opposite fashion, by increasing the formation of blood clots (also called thrombi) that can obstruct blood flow. Taking into account available evidence of…
Article
After 6 years of the epidemic that put Northeast Brazil in its epicenter, the Zika virus and its consequences may be away from the spotlight, but it is still a burden that needs to be addressed. From March 15th to18th, researchers from the four corners of the world who participated in one of the greatest Zika research consortiums gathered virtually (due to the current pandemic) to discuss its results and ways forward. The event marked the closing of the project, which promoted studies in a variety of areas from clinical research, to entomology and social science research.
Researchers…
Article
A methodology that aims to make the monitoring of the new coronavirus variants simpler and faster, besides being cheaper, has just been developed at Fiocruz Pernambuco. It is based on a technique that is already widely used and available in Brazil and in the world, the Sanger sequencing - also called sequencing by capillary electrophoresis. The article with this finding has just been made available online as a preprint on the MedRxiv platform.
Matheus Bezerra e Viviane Carvalho (Photo: Ascom/Fiocruz PE)
The test was developed by the Fiocruz Pernambuco team that monitors Sars-CoV-…
Article
On April 14, the Oswaldo Cruz Foundation will hold the first PrInt Fiocruz-Capes virtual seminar in 2021. The event is part of a series of integrated seminars between researchers from Fiocruz and Germany, with a diverse thematic. The meeting will be held from 9 am to 11:30 am (Brasilia Time), with transmission through the Fiocruz channel on YouTube.
The seminar, which is aimed at Fiocruz students, seeks to stimulate interest in scientific and cultural training associated with other countries. During the year, meetings will also be organized for more direct contact with German foundations and…
Article
A paper to be published in May in the U.S. Centers for Disease Control and Prevention's (CDC/US) journal Emerging Infectious Diseases (EID) shows that a first exposure to COVID-19 in mild or asymptomatic cases may not produce an immune response, and that a person can reinfect himself or herself with the same variant. The second infection can cause stronger symptoms than the first, the study indicates.
(Photo:Isabela Carrari - Prefeitura de Santos)
The article Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil was coordinated by researcher…
Article
With the start of Oxford/AstraZeneca-Fiocruz production vaccine on national territory, and the batches delivery to the Ministry of Health, this stage is beginning to give its first results to Brazilian society. Still this year, the country will have a vaccine produced entirely in Brazil and already in this first semester the manufacture of the first batches of the active pharmaceutical ingredient (API) will start, which should be available to the population in the second semester. It will be a vaccine 100% produced in Brazil. But Fiocruz continues, in a complementary way, to support the…
Article
The Bulletin of the Fiocruz Covid-19 Observatory, released on March 26, shows that the country is facing the collapse of the health system. At the same time, the pandemic is now taking up new shapes, affecting younger age groups: 30 to 39 years old, 40 to 49, and 50 to 59. In such a scenario, researchers defend the adoption of measures in two interconnected groups.
The first group includes urgent measures that involve the containment of the rates of transmission and growth of cases by employing blocking or lockdown measures, accompanied by the increased number of beds with quality and safety…
Article
This March 2021, the Pan American Health Organization/World Health Organization (PAHO/WHO) designated the National Institute for Women's, Children's and Adolescent Health Fernandes Figueira (IFF/Fiocruz) as a PAHO/WHO Collaborating Center to strengthen Human Milk Banks. The designation as a Collaborating Center will be valid for a four years period, starting on March 3, 2021, and can be renewed by redesignation.
The designation as a Paho/WHO partner is valid for four years (Photo: Peter Ilicciev)
A Collaborating Center is an institution designated by the World Health Organization…
Article
Executive:
Viviane Santos de Oliveira Veiga
Fundação Oswaldo Cruz (FIOCRUZ)
Maria Luiza Machado Campos
Universidade Federal do Rio de Janeiro (UFRJ)
João Luiz Rebelo Moreira
University of Twente (International Representative)
Patricia Corrêa Henning
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Luiz Olavo Bonino da Silva Santos
VODAN IN consultant
Researchers:
Sergio Manuel Serra da Cruz
Universidade Federal do Rio de Janeiro (UFRJ)
Giseli Rabello Lopes
Universidade Federal do Rio de Janeiro (UFRJ)
Development:
Vânia Jesus de Araujo Soares Borges
Universidade Federal…
Basic page
Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Carlos Roberto Lyra da Silva - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Gaffree Guinle Hospital
Romero de Melo Silva - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Sérgio Luis Teixeira de Aquino - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Jorge da Cunha Barbosa Leite - Universidade Federal do Estado do Rio de Janeiro (UNIRIO)
Municipal São José de Duque de Caxias Hospital
Antonio Pontes Neto - Hospital Municipal São José de Duque de Caxias
Carlos Antonio da Silva - Hospital Municipal…
Basic page
The VODAN Brazil Implementation Network was established through the efforts of teams from the Oswaldo Cruz Foundation (Fiocruz), Federal University of Rio de Janeiro (UFRJ), Federal University of the State of Rio de Janeiro (UNIRIO) and São José Municipal Hospital. The Vodan Brazil aims to provide an infrastructure capable of enabling health units to collect and manage medical data of patients infected with COVID-19.
During the first phase of the project, a collection of patient data from each hospital is collect using the COVID-19 CASE RECORD FORM, adopted by the World Health…
Basic page
Scientists at the Fiocruz Genomics Network have identified important changes in the Spike (S) protein structure of the Sars-CoV-2 virus circulating in Brazil. Eleven gene sequences showed deletions (loss of genetic material) in the initial region of the protein and in four there was some amino acids insertion. The Spike protein is associated with the pathogen's ability to enter human cells and is one of the main targets of the neutralizing antibodies produced by the body to block the virus.
Photo:Josué Damacena, IOC/Fiocruz
The discovery is the result of genomic surveillance conducted…
Article
Science formulated with collaboration and transparency. On March 17th, the Oswaldo Cruz Foundation (Fiocruz) presented the advances in the implantation of the Institutional Data Repository for Research - Arca Dados, an important element to implement the Policy for Management, Sharing and Opening of Data for Research. The document (approved in September 2020 by the Deliberative Council of Fiocruz and whose Ordinance came into term in December) is now available in a publication in Portuguese and English: you can access both versions here.
By printing its principles and guidelines, the…
Article
The United Kingdom ambassador in Brazil, Peter Wilson, visited the Oswaldo Cruz Foundation (Fiocruz) on March 5 for a meeting with the president of the institution, Nísia Trindade Lima, and to visit the Immunobiological Technology Institute (Bio-Manguinhos) plant that is producing the Covid-19 Fiocruz vaccine.
Photo: Pedro Paulo Gonçalves
“I greatly admire the work you have you been doing, and we are here to know how we can help”, explained the Ambassador. Fiocruz president stated that Fiocruz has “a historical partnership with the United Kingdom and the pandemic has highlighted the…
Article
Edgar Marcelino de Carvalho, a researcher of Fiocruz Bahia, was considered the world’s greatest specialist in cutaneous leishmaniasis by the site Expertscape. The ranking was based on science publications: Carvalho published 84 papers on the subject between 2010 and 2021. The ranking includes the 66 scientists with most papers published on cutaneous leishmaniasis from all over the world and also includes three other researchers of Fiocruz Bahia, Lucas Pedreira de Carvalho, Aldina Prado Barral, and Manoel Barral-Netto.
In the field of cutaneous leishmaniasis, no other institution has better…
Article
Six years after the National Health Emergency declared by the Brazilian Ministry of Health, Zika is still a public health issue that mobilizes many actors in society. Fiocruz is launching the virtual exhibition Zika: lives affecting lives, produced by the Zika Social Sciences Network and the Oswaldo Cruz House (COC/Fiocruz), through the Museum of Life. The exhibition is the result of collaborative scientific research, produced with intense social participation, and its goal is to raise awareness regarding the fact that Congenital Zika Virus Syndrome (CZVS) goes beyond microcephaly, which is…
Article